The continued development and availability of ultrahigh field MRI systems along with recent FDA approval of 7T for head and knee imaging, creates the timely opportunity for a discussion among imaging centers about how this technology can positively impact clinical care. Identifying key clinical applications and developing workflows to integrate sometimes complex methods into the mainstream, require a dedicated focus of leading imaging centers currently involved in high field imaging and those individuals interested in exploring and demonstrating its potential to improve patient outcomes.
With leadership from the University of Minnesota Center for Magnetic Resonance Research, and support from the University of Minnesota’s CTSA hub, the UMN Clinical and Translational Science Institute, this meeting endeavors to bring together clinicians and scientists from within the national CTSA network to discuss these topics. The goals of the meeting are three-fold:
- Identify the promise of ultrahigh field MRI at addressing unmet clinical needs.
- Highlight the current and future technologies required to fully exploit 7T in addressing these applications.
- Begin to discuss the cost-benefit question, “Will the availability of 7T improve clinical outcomes?”.